Omega-3 supplementation in juvenile bipolar disorder

Tanya L. Hanstock, Stehen J. Hirneth, Colin J. Kable, Manohar L. Garg, Philip L. Hazell, Edward Clayton

    Research output: Book chapter/Published conference paperConference paperpeer-review


    Background: Supplementation with long-chain omega-3 polyunsaturated fatty acids (LCn-3PUFA), including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), may be beneficial in the treatment of depression in children and bipolar disorder (BD) in adults. Aims: To examine the change in symptoms of mania and depression in participants with juvenile BD (JBD) following supplementation with LCn-3PUFA. Method: Eighteen participants with JBD received supplements containing 1.92 g day 1 LCn-3PUFA, including 360 mg day 1 EPA and 1560 mg day 1 DHA, for 6 weeks. Fasting Red Blood Cell (RBC) LCn-3PUFA, mania, depression and global function were measured before and after supplementation. Results: RBC EPA and DHA increased significantly following supplementation. Symptoms of mania and depression were significantly lower and global functioning was significantly higher following supplementation. Changes in RBC LCn-3PUFA were not significantly related to changes in mania or depression. Conclusion: Supplementation with omega-3 was associated with a reduction in mania and depression in participants with JBD when given in an open-label manner. A larger randomised controlled trial appears warranted in this participant population.
    Original languageEnglish
    Title of host publicationAustraliasian Society for Psychiatric Research
    EditorsPeter Joyce
    Place of PublicationLondon
    PublisherInforma Healthcare USA
    Publication statusPublished - 2008
    EventAustralian and New Zealand Journal of Psychiatry - Newcastle
    Duration: 02 Dec 200805 Dec 2008


    ConferenceAustralian and New Zealand Journal of Psychiatry


    Dive into the research topics of 'Omega-3 supplementation in juvenile bipolar disorder'. Together they form a unique fingerprint.

    Cite this